Increasing Understanding Regarding the Risk of Concomitant Use of Carbamazepine and Direct Oral Anticoagulants

Abstract

Get full access to this article

View all access options for this article.

References

Mohammed

Korkis

Garwood

. Incorporating comprehensive management of direct oral anticoagulants into anticoagulation clinics. Pharmacotherapy. 2017;37(10):1284–1296.

Akamine

Uehara

Miura

. Multiple inductive effects of carbamazepine on combined therapy with paliperidone and amlodipine. J Clin Pharmacy Ther. 2015;40(4):480–482.

Stollberger

Finsterer

. Recurrent venous thrombosis under rivaroxaban and carbamazepine for symptomatic epilepsy. Neurol Neurochir Pol. 2017;51(2):194–196.

Backman

Olkkola

Ojala

. Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbamazepine or phenytoin. Epilepsia. 1996;37(3):253–257.

Strunets

Mirza

Sra

. Novel anticoagulants for stroke prevention in atrial fibrillation: safety issues in the elderly. Expert Rev Clin Pharmacol. 2013;6(6):677–689.

Lin

. CYP induction-mediated drug interactions: in vitro assessment and clinical implications. Pharm Res. 2006;23(6):1089–1116.

Fitzgerald

Howes

. Drug interactions of direct-oral anticoagulants. Drug Saf. 2016;39(9):841–845.

Hager

Bolt

Albers

. Development of left atrial thrombus after coadministration of dabigatran etexilate and phenytoin. Can J Cardiol. 2017;33(4):554.e13–e14.

Douxfils

Mullier

Loosen

. Assessment of the impact of rivaroxaban on coagulation assays: laboratory recommendations for monitoring of rivaroxaban and review of the literature. Thromb Res. 2012;130(6):956–966.

10.

Xarelto (rivaroxaban) [US prescribing information]. Janssen Pharmaceuticals Inc; 2017. http://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/XARELTO-pi.pdf.

11.

Baxter

Preston

, eds. Stockley’s Drug Interactions [online]. London, United Kingdom: Pharmaceutical Press. http://www.medicines-complete.com. Accessed December 2017.

12.

Eliquis (apixaban) [US prescribing information]. Bristol-Myers Squibb Co; 2016. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202155s000lbl.pdf.